Latest News
Aracari Biosciences wins Startup World Cup Southern California 2022
IRVINE, CA, August 11th, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it has won the Startup World Cup Southern California held on August 11th,
Dr. Chris Hughes to speak at BioInsights’ Immuno-Oncology Insights
IRVINE, CA, June 1, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that Dr. Chris Hughes, Chief Scientific Officer, will be speaking at BioInsights’ Immuno-Oncology Insights
Aracari Bioscience to present at first MPS World Summit
IRVINE, CA, May 31, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it will present at the first MPS World Summit to be held in
National Institute of Health (NIH) awards Aracari Biosciences to commercialize bone marrow platform that models in vivo drug responses
Aracari Biosciences, Inc. (“Aracari”) announced that it has received a grant from the National Institute of Health to further develop Aracari’s proprietary human bone marrow technology that models in vivo drug responses.
National Science Foundation (NSF) awards Aracari Biosciences Phase II SBIR grant to commercialize the Vasoreactive Vascularized Micro-Organ (VMO-VA) platform
Aracari Biosciences, Inc. announces a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform.
Aracari Biosciences wins Startup World Cup Southern California 2022
IRVINE, CA, August 11th, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it has won the Startup World Cup Southern California held on August 11th,
Dr. Chris Hughes to speak at BioInsights’ Immuno-Oncology Insights
IRVINE, CA, June 1, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that Dr. Chris Hughes, Chief Scientific Officer, will be speaking at BioInsights’ Immuno-Oncology Insights
Aracari Bioscience to present at first MPS World Summit
IRVINE, CA, May 31, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it will present at the first MPS World Summit to be held in
National Institute of Health (NIH) awards Aracari Biosciences to commercialize bone marrow platform that models in vivo drug responses
Aracari Biosciences, Inc. (“Aracari”) announced that it has received a grant from the National Institute of Health to further develop Aracari’s proprietary human bone marrow technology that models in vivo drug responses.
National Science Foundation (NSF) awards Aracari Biosciences Phase II SBIR grant to commercialize the Vasoreactive Vascularized Micro-Organ (VMO-VA) platform
Aracari Biosciences, Inc. announces a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform.
